NB
UTHR icon

Nicolet Bankshares’s United Therapeutics UTHR Stock Holding History

Nicolet Bankshares’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.46M Sell
6,393
-1,034
-14% -$582K 0.11% 144
2026
Q1 		$4.4M Buy
+7,427
New +$3.7M 0.16% 106

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Nicolet Bankshares's UTHR Position: Q2 2026 in Review

Nicolet Bankshares reduced its United Therapeutics (UTHR) stake by 14% in Q2 2026, selling an estimated $582K and leaving 6,393 shares worth $3.46M. The position accounts for 0.11% of the portfolio, ranked #144.

Nicolet Bankshares first reported a position in UTHR in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.4M in Q1 2026. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Nicolet Bankshares held 6,393 shares of United Therapeutics worth $3.46M as of Q2 2026.
  • Nicolet Bankshares sold 1,034 United Therapeutics shares in Q2 2026, an estimated $582K.
  • United Therapeutics made up 0.11% of Nicolet Bankshares's portfolio in Q2 2026, its #144 holding.
  • Nicolet Bankshares first reported a position in United Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Nicolet Bankshares's United Therapeutics position peaked at $4.4M in Q1 2026.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Nicolet Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.